# Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

> **NCT00482170** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 421 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DEVICE:** Enbrel (etanercept)
- **DEVICE:** Etanercept

## Key facts

- **NCT ID:** NCT00482170
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-04
- **Final completion:** 2009-09
- **Target enrollment:** 421 (ACTUAL)
- **Last updated:** 2012-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00482170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00482170, "Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00482170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*